Publications

1. Grieco A, Miele L, Gasbarrini G,  Grillo R. Sporadic HEV hepatitis in Italy. Gut 2001; 48: 580.
2. Grieco A, Alfei B, Di Rocco P, Miele L, Biolcati GF, Griso D, Vecchio FM, Bianco A, Gasbarrini G. Non alcoholic steatohepatitis (NASH) induced by carbamazepine and variegate porphyria. Eur J Gastroenterol Hepatol 2001 Aug;13(8):973-5.
3. Grieco A, Miele L, Pignataro G, Pompili M, Rapaccini GL, Gasbarrini G. Is Coeliac Disease a confounding factor in diagnosis of NASH? Gut 2001; 49 (4): 596.
4. Grieco A, Forgione A, Giorgi A, Miele L, Gasbarrini G. Propafenone-related cholestatic hepatitis in an elderly patient.  Ital Heart J 2002 Jul;3(7):431-4.
5. Bianco A, Pitocco D, Valenza V, Caputo S, Grieco A, Miele L, Greco AV, Ghirlanda G. Effect of  Sildenafil on diabetic gastropathy. Diabetes Care. 2002 Oct; 25(10):1888-9.
6. Grieco A, Miele L, Giorgi A, Civello IM, Gasbarrini G. Acute cholestatic hepatitis associated with Celecoxib. Ann Pharmacother. 2002 Dec;36(12):1887-9.
7. Armuzzi A, Candelli M, Zocco MA, Andreoli A, De Lorenzo A, Nista EC, Miele L, Cremonini F, Cazzato IA, Grieco A, Gasbarrini G, Gasbarrini A. Breath testing for human liver function assessment. Aliment Pharmacol Ther. 2002 Dec;16(12):1977-96.
8. Manna R, Miele L, La Regina M, Grieco A,  Gasbarrini G. Crioglobulinaemia: a true internistic disease? Int J Immunopathol Pharmacol. 2003 Jan-Apr; 16(1):33-41.
9. Grieco A, Marcoccia S,  Miele L, Marmiroli L, Caminiti G, Ragazzoni E, Cotroneo AR, Ausili Cefaro G, Rapaccini GL, Gasbarrini G. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival. Hepatogastroenterology. 2003 Jan-Feb; 50(49):207-12.
10. Grieco A, Cavallaro A, Potenza AE, Mulè A, Tarquini E, Miele L, Gasbarrini G. Gastrointestinal Stromal Tumor (GIST) and Ulcerative Colitis. Case report and review of literature. J Exp Clin Canc Res. 2002; 21 (4): 617-20.
11. Urgesi R, Cianci R, Miele L, Martino A, Cesaro P, Pirozzi G, Vero V, Gasbarrini G, Cammarota G, De Lorenzo A. [Diverticuli of the colon]. Recenti Prog Med. 2003 Sep;94(9):399-407.
12. Grieco A, Miele L, Gasbarrini G. Reply to: Waldum HL. Comment: Acute Cholestatic Hepatitis Associated with Celecoxib. Ann Pharmacother 2003 Mar; 37(5):748.
13. Miele L, Grieco A, Armuzzi A, Candelli M, Forgione A, Gasbarrini A, Gasbarrini G. Hepatic mitochondrial beta-oxidation in patients with Nonalcoholic-Steatohepatitis assessed  by  13C-Octanoate Breath Test. Am J Gastroenterol 2003 Oct;98(10):2335-6.
14. Gasbarrini G, Miele L, Grieco A. [Drug-induced hepatitis] Ann Ital Med Int. 2003 Jul-Sep; 18(3):167-8. PMID: 14621428
15. Cammarota G, Cianci R, Miele L, Martino A, Vero V, Forgione A, Grieco A, Gasbarrini G. [Gastroesophageal reflux disease: facts and uncertainties.] Recenti Prog Med. 2004 Jan; 95(1):35-9; quiz 59.
16. Cammarota G, Martino A, Pirozzi G, Cianci R, Branca G, Nista EC, Cazzato A, Cannizzaro O, Miele L, Grieco A, Gasbarrini A, Gasbarrini G. High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection. Aliment Pharmacol Ther. 2004 Apr; 19(7):789-95.
17. Grieco A, Caminiti G, Miele L, Doglietto GB, Gasbarrini G. “Tear-drop shaped” HCC. Annals of Hepatology 2003; 2(3): July-September: 140.
18. Candelli M, Cazzato IA, Zocco MA, Nista EC, Fini A, Armuzzi A, Camise V, Santoro M, Miele L, Grieco A, Gasbarrini G, Gasbarrini A. 13C-Breath Test in the study of mitochondrial liver function. Eur Rev Med Pharmacol Sci. 2004; 8: 23-31.
19. Nista EC, Fini A, Armuzzi A, Candelli M, Zocco MA, Cazzato IA, Merra G, Finizio R, Miele L, Grieco A, Gasbarrini G, Gasbarrini A. 13C-Breath Test in the study of microsomal liver function. Eur Rev Med Pharmacol Sci. 2004; 8: 33-46.
20. Loguercio C, De Simone T, D'Auria MV, de Sio I, Federico A, Tuccillo C, Abbatecola AM, Del Vecchio Blanco C; Italian AISF Clinical Group. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. Dig Liver Dis. 2004 Jun;36(6):398-405.
21. Capaldi L, Ursella S, Miele L, Larussa D, Pallavicini F, Gasbarrini G, Grieco A, Gentiloni Silveri N. A “progressive” visual loss. PMID: 15317272 - Ann Ital Med Int 2004: 19 (2):118-21
22. Montalto M, Miele L, Marcheggiano A, Santoro L, Curigliano V, Vastola M, Gasbarrini G. Anisakis infestation: a case of acute abdomen mimicking Crohn's disease and eosinophilic gastroenteritis. Dig Liver Dis. 2005 Jan;37(1):62-4. PMID: 15702862 - doi:10.1016/j.dld.2004.05.014.
23. Grieco A, Pompili M, Caminiti G, Miele L, Covino M, Alfei B, Rapaccini GL, Gasbarrini G. Prognostic factors for survival in patients with early-intermediate HCC undergoing non surgical therapy: comparison of Okuda, CLIP and BCLC staging systems in a single Italian centre. Gut. 2005 Mar;54(3):411-8.
    Comment in: Ryder S.Predicting survival in early hepatocellular carcinoma. Gut. 2005 Mar; 54(3):328-9.
    Comment in: Huo TI, Huang YH, Lee SD, Wu JC. Is there an ideal prognostic model for hepatocellular carcinoma? Gut. 2005 Sep;54(9):1348.
24. Miele L, Vero V, Gasbarrini G, Grieco A. Braised liver with herbs: the risk of nathuropathic hepatoprotection J Clin Gastroenterol 2005 Apr; 39 (4):344.
25. Famularo G, Minisola G, Grieco A, Miele L. Fulminant liver failure caused by cyproterone. Dig Liver Dis 2005; 37(9):718-9.
26. Grieco A, Miele L, Gasbarrini G. NAFLD and NASH: behind the fat, there’s something more. Eur Rev Med Pharmacol Sci 2005; 9: 249-250.
27. Gasbarrini G, Vero V, Miele L, Forgione A, Hernandez AP, Greco AV, Gasbarrini A, Grieco A. Nonalcoholic fatty liver disease: defining a common problem. Eur Rev Med Pharmacol Sci 2005; 9: 253-259.
28. Grieco A, Forgione A, Miele L, Vero V, Greco AV, Gasbarrini A, Gasbarrini G. Fatty liver and drugs. Eur Rev Med Pharmacol Sci 2005; 9: 261-263.
29. Capristo E, Miele L, Forgione A, Vero V, Farnetti S, Mingrone G, Greco AV, Gasbarrini G, Grieco A. Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH). Eur Rev Med Pharmacol Sci 2005; 9: 265-268.
30. Santoliquido A, Di Campli C, Miele L, Gabrieli ML, Forgione A, Zocco MA, Lupascu A, Di Giorgio A, Flore R, Pola P, Gasbarrini G, Gasbarrini A, Tondi P, Grieco A. Hepatic steatosis and vascular disease. Eur Rev Med Pharmacol Sci 2005; 9: 269-271.
31. Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, Greco AV, Gasbarrini G, Gasbarrini A, Grieco A. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. Eur Rev Med Pharmacol Sci 2005; 9: 273-278.
32. Patriarca G, Pogna N, Cammarota G, Schiavino D, Lombardo C, Pollastrini E, De Pasquale T, Buonomo A, Nocente F, Gazza L, Pietrini D, Miele L, Nucera E, Gasbarrini G. An attempt of specific desensitising treatment with gliadin in celiac disease. Int J Immunopathol Pharmacol. 2005 Oct-Dec; 18(4):709-14.
33. Cianci R, Pinti M, Nasi M, Starnino S, Cammarota G, Miele L, De Luca A, Cauda R, Raducci F, Grieco A, Rapaccini G, Gasbarrini G, Cossarizza A, Pandolfi F. Impairment of recent thymic emigrants in HCV infection. Int J Immunopathol Pharmacol. 2005 Oct-Dec;18(4):723-8.
34. Miele L, Gabrieli ML, Forgione A, Vero V, Gallo A, Capristo E, Gasbarrini G, Grieco A. Oxidative stress in Metabolic Syndrome and Nonalcoholic steatohepatitis (NASH). A role for vitamins in clinical practice. Recenti Prog Med. 2006; 97 (1): 1-5
35. PiccilloGA, Miele L, Mondati E, Moro PA, Musco A, Forgione A, Gasbarrini G, Grieco A. Anticholinergic syndrome due to “Devil’s herb”: when risks come from the ancient time. Int J Clin Pract 2006; 60 (4):492–4.
36. D'Onofrio F, Miele L, Diaco M, Santoro L, De Socio G, Montalto M, Grieco A, Gasbarrini G, Manna R. Sjogren's syndrome in a celiac patient: searching for environmental triggers. Int J Immunopathol Pharmacol. 2006 Apr-Jun;19(2):445-8.
37. La Torre G, Miele L,  Mannocci A, Chiaradia G, Berloco F, Gabrieli ML, Gasbarrini G, Ricciardi G, Grieco A. Intrafamilial transmission of HCV in Central Italy: Risk factors. BMC Public Health. 2006 Sep 25; 6:237.
38. Piccillo GA, Miele L, Mondati EGM, Scuderi R, Nicolosi M, Forgione A, Gabrieli ML, Cefalo C, Gasbarrini G, Grieco A. Eighteen needles to forget… an unnamed past. Journal of Forensic and Legal Medicine. 2007; 14: 304-6. (Formerly Journal of Clinical Forensic Medicine)
39. Ursella S, Miele L, Pirronti T, Forgione A, Gasbarrini G, Gentiloni Silveri N, Grieco A. Thromboembolism and breast cancer: the hidden risk for patient and physician.  Intern Med J. 2007 Feb;37(2):133-4. PMID: 17229259 - doi:10.1111/j.1445-5994.2006.01248.x
40. Miele L, Forgione A, Gasbarrini G, Grieco A. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Transl Research 2007;149:114–125 PMID: 17320797 - doi:10.1016/j.trsl.2006.11.011 (Formerly Journal of Laboratory and Clinical Medicine)
41. Forgione A, Miele L, Gasbarrini G, Grieco A. Alcoholic and nonalcoholic forms of fatty liver disease. Minerva Gastroenterol Dietol. 2007 Mar;53(1):83-100. PMID: 17415346
42. Famularo G, Miele L, Minisola G, Grieco A. Liver toxicity on rosuvastatin therapy. World J Gastroenterol 2007 February 28; 13(8): 1286-1288. PMID: 17451217
43. Cammarota G, Cesaro P, La Mura R, Martino A, Cazzato A, Miele L, Lupascu A, Vecchio FM, Larocca LM, Grieco A, Gasbarrini G. Role of the “immersion technique” in diagnosing celiac disease with villous atrophy limited to the duodenal bulb. J Clin Gastroenterol. 2007 Jul;41(6):571-575. PMID: 17577113
44. La Torre G, Miele L, Mannocci A, Reali M, Gasbarrini G, De Vito E,  Grieco A, Ricciardi W. Socio-demographic determinants of coinfections by HIV, hepatitis B and C viruses among prisoners of Central Italy. BMC Infectious Diseases 2007, 7:100. PMID: 17760979 - doi:10.1186/1471-2334-7-100.
45. Di Sabatino A, Rosado MM, Miele L, Capolonghi F, Cazzola P, Biancheri P, Carsetti R, Gasbarrini G, Corazza GR. Impairment of splenic IgM-memory but not switched-memory B-cells in a patient with celiac disease and splenic atrophy. J Allergy Clin Immunol. 2007 Dec; 120(6):1461-3. PMID: 17889288 - doi:10.1016/j.jaci.2007.07.054.
46. Miele L, Pierconti F, Forgione A, Vero V, Cammarota G, Molinari F, Masselli G, Capristo E, Martini M, Larocca LM, Civello IM, Gasbarrini G, Grieco A. Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. Eur J Gastroenterol Hepatol 2007, 19 (11):1026–1030. PMID: 18049176
47. Candelli M, Armuzzi A, Miele L, Nista EC, Pignataro G, Zileri dal Verme L, Grieco A, Gasbarrini G, Gasbarrini A. Gender affects 13C-Ketoisocaproic Acid Breath Test. Eur Rev Med Pharmacol Sci. 2007 Nov-Dec;11(6):401-6. PMID: 18306908
48. Grieco A, Miele L, Forgione A,  Ragazzoni E, Vecchio FM, Gasbarrini G. Mild hepatitis due to recommended doses of acetaminophen in patients with evidence of constitutionally enhanced cytochrome P450 sistem activity. J Clin Pharm Ther. 2008 Jun;33(3):315-20. PMID: 18452419
49. Miele L, Beale G, Patman G, Nobili V, Leathart J, Grieco A, Abate M, Friedman SL, Narla G, Bugianesi E, Day CP, Reeves HL. The Kruppel Like Factor 6 (KLF6) genotype is associated with fibrosis in non-alcoholic fatty liver disease (NAFLD). Gastroenterology 2008 Jul;135(1):282-291. PMID: 18515091 - doi: 10.1053/j.gastro.2008.04.004
    Comment in: Watanabe K, Ohnishi S, Manabe I, Nagai R, Kadowaki T.KLF6 in nonalcoholic fatty liver disease: role of fibrogenesis and carcinogenesis. Gastroenterology. 2008 Jul;135(1):309-12.
50. Palladino M, Miele L, Pompili M, Forgione A, Vellone V, Vecchio FM, Chiusolo P, Laurenti L, Sica S, Grieco A. Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. Clin Transplant. 2008 Nov-Dec; 22(6):837-41. PMID: 18713263
51. Candelli M, Miele L, Armuzzi A, Nista EC, Pignataro G, Fini L, Cazzato IA, Zocco MA, Bartolozzi F, Gasbarrini G, Grieco A, Gasbarrini A. 13C-Methionine Breath Tests for mitochondrial liver function assessment. Eur Rev Med Pharmacol Sci. 2008 Jul-Aug;12(4):245-9. PMID: 18727456
52. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Mascianà R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, Grieco A. Increased intestinal permeability and tight junction alterations in non-alcoholic fatty liver disease (NAFLD). Hepatology. 2009 Jun;49(6):1877-87. PMID: 19291785.
    Comment in:  Hepatology. 2009 Jun; 49(6):1790-2.
53. Gasbarrini G, Miele L, Malandrino N, Grieco A, Addolorato G, Gasbarrini A, Cammarota G, Bonvicini F. Celiac disease in the 21st century: issues of under- and over-diagnosis. Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):1-7. PMID: 19309546.
54. Grieco A, Miele L, Pompili M, Biolato M, Vecchio FM, Grattagliano I, Gasbarrini G. Acute hepatitis caused by a natural lipid-lowering product: When “alternative” medicine is no “alternative” at all. J Hepatol. 2009 Jun;50(6):1273-7. PMID: 19398239
55. Targher G, Chonchol M, Miele L, Zoppini G, Pichiri I, Muggeo M. Non-alcoholic Fatty Liver Disease as a Contributor to Hypercoagulation and Thrombophilia in the Metabolic Syndrome. Semin Thromb Hemost 2009; 35 (3):277-87. doi: 10.1055/s-0029-1222606. PMID: 19452403.
56. Vero V, Racco S, Biolato M, Pompili M, Gasbarrini G, Miele L, Grieco A. The treatment of hepatocellular carcinoma: an update. Minerva Med. 2009 Jun;100(3):173-193. PMID: 19571783
57. Gray J, Chattopadhyay D, Beale G, Patman G, Miele L, King B, Stewart S, Hudson M, Day CP, Manas D, Reeves H. A Proteomic Strategy to Identify Novel Serum Biomarkers for Liver Cirrhosis and Hepatocellular Cancer in Fatty Liver Disease. BMC Cancer 2009 Aug 5;9(1):271. PMID: 19656391
58. Miele L, Vallone S, Cefalo C, Di Stasi C, D’Agostino M, La Torre G, Vecchio FM, Gabrieli ML, Vero V, Biolato M, Pompili M, Rapaccini GL, Amerio P, De Simone C, Grieco A. Prevalence, characteristics, and severity of nonalcoholic fatty liver disease (NAFLD) in patients with psoriasis. J Hepatol. 2009 Oct;51(4):778-86. Epub 2009 Jun 26.PMID: 1966483
59. De Waure C, Cefalo C,  Chiaradia G, Sferrazza A, Miele L, Gasbarrini G, Ricciardi W,Grieco A, La Torre G. Intrafamilial transmission of hepatitis C virus in Italy: a systematic review. J Epidemiol Community Health. 2010 Oct;64(10):843-8. Epub 2009 Aug 25. PMID: 19710041
60. Miele L, Forgione A, La Torre G, Vero V, Cefalo C, Vecchio FM, Rapaccini GL, Gasbarrini G, Neuman MG, Grieco A. Serum levels of Hyaluronic Acid and TIMP I combined with age predict the presence of non-alcoholic steatohepatitis (NASH) in subjects with Nonalcoholic Fatty Liver Disease (NAFLD). Transl Res. 2009 Oct;154(4):194-201. PMID: 19766963
61. Biolato M, Miele L, Gasbarrini G, Grieco A. Abdominal angina. Am J Med Sci 2009; 338(3): 1-7. PMID: 19794303.
62. Morisco F, Stroffolini T, Medda E, Amoruso DC, Almasio PL, Villa E, Zuin M, Paris B, Stanzione M, Caporaso N; NADIR Study Group.Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study. J Viral Hepat. 2010 Jun;17(6):427-34. PMID: 19780939
63. Piccolo P, Lenci I, Telesca C, Di Paolo D, Bandiera F, De Melia L, Sorbello O, Renier G, Ricci GL, Nosotti L, Romano M, De Santis A, Levrero M, Antonucci G, Longo MA, Annicchiarico BE, Angelico M; Hep B Free Network Investigators. Patterns of chronic hepatitis B in Central Italy: a cross-sectional study. Eur J Public Health. 2010 Dec;20(6):711-3. PMID: 19884157
64. Gasbarrini G, Racco S, Franceschi F, Miele L, Cammarota G, Grieco A, Gasbarrini A. Helicobacter pylori infection: from gastric to systemic disease. Recenti Prog Med. 2010 Jan;101(1):27-33. PMID: 20391683.
65. Biolato M, Marrone G, Racco S, Di Stasi C, Miele L, Gasbarrini G, Landolfi R, Grieco A. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? Eur Rev Med Pharmacol Sci. 2010 Apr; 14(4):356-62. PMID: 20496548
66. Porto I, Leo A, Miele L, Pompili M, Landolfi R, Crea F. Acase of variant angina in a patient under chronic treatment with sorafenib. Nat Rev Clin Oncol. 2010 Aug;7(8):476-80. PMID: 20479781
67. Gasbarrini G, Miele L, Corazza GR, Gasbarrini A. When was Celiac Disease born? The Italian case from the archeological site of Cosa. J Clin Gastroenterol. 2010 Aug;44(7):502-3.PMID: 20631553.
68. Fracanzani AL, Valenti L, Bugianesi E, Vanni E, Grieco A, Miele L, Consonni D, Fatta E, Lombardi R, Marchesini G, Fargion S. Risk of Nonalcoholic Steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. J Hepatol. 2011 Jun; 54(6):1244-9. PMID: 21145841
    Comment in: Machado MV, Cortez-Pinto H. No need for a large belly to have NASH. J Hepatol. 2011 Jun; 54(6):1090-3.
69. Miele L, Cefalo C, Forgione A, Gasbarrini G, Grieco A. Recent knowledges on the pathogenesis of nonalcoholic fatty liver disease. Role of genetic factors.Recenti Prog Med. 2010 Sep;101(9):359-63.PMID: 21268374
70. Gangale MF, Miele L, Lanzone A, Sagnella F, Martinez D, Tropea A, Moro F, Morciano A, Ciardulli A, Palla C, Pompili M, Cefalo C, Grieco A, Apa R. Long term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome.Clin Endocrinol (Oxf). 2011; 75, 520–7
71. Pompili M, Nicolardi E, Abate V, Miele L, Riccardi L, Covino M, Grieco A, Rapaccini GL, Landolfi R.  Percutaneous ethanol injection in the treatment of unifocal hepatocellular carcinoma: favourable outcome of patients with single tumor smaller than 2 cm. World JGastroenterol2011 Jul 14;17(26):3126-32
72. Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Rossi M, Tisone G, Lupo L, Romagnoli R, Vitale A, Cucchetti A, Mazzaferro V, Gruttadauria S, Caccamo L, Burra P, Nicolotti N, Agnes S on behalf of the Donor-to-Recipient Italian Liver(D2R-ILTx) Study Group. Balancing donor and recipient risk factors in liver transplantation. The value of D-MELD with particular reference to HCV recipients in Italy.Am J Transplant. 2011 Sep 15. doi: 10.1111/j.1600-6143.2011.03732.x.
73. Bechmann LP, Gastaldelli A, Vetter D, Patman GL, Pascoe L, Hannivoort RA, Lee UE, Fiel MI, Muñoz U, Ciociaro D, Buzzigoli E, Miele L, Bugianesi E, Burt AD, Day CP, Agius L, Walker M, Friedman SL, Reeves HL. Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity and NAFLD pathogenesis.Hepatology. 2011 Nov 16. doi: 10.1002/hep.24793.
74. Fusco A, Miele L, D'Uonnolo A, Forgione A, Riccardi L, Cefalo C, Barini A, Bianchi A, Giampietro A, Cimino V, Landolfi R, Grieco A, De Marinis L.Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels.Clin Endocrinol (Oxf). 2011 Nov 11. doi: 10.1111/j.1365-2265.2011.04291.x.
75. De Feo E, Cefalo C, Arzani D, Amore R, Landolfi R, Grieco A, Ricciardi W, Miele L, Boccia S. A case-control study on the effects of the Apoliprotein E genotypes in Nonalcoholic Fatty Liver Disease.Molecular Biology Reports 2012. doi: 10.1007/s11033-012-1570-7
76. Loguercio C, Andreone P, Brisc C, Brisc MC, Bugianesi E, Chiaramonte M, Cursaro C, Danila M, de Sio I, Floreani A, Freni MA, Grieco A, Groppo M, Lazzari R, Lobello S, Lorefice E, Margotti M, Miele L, Milani S, Okolicsanyi L, Palasciano G, Portincasa P, Saltarelli P, Smedile A, Somalvico F, Spadaro A, Sporea I, Sorrentino P, Vecchione R, Tuccillo C, Del Vecchio Blanco C, Federico A.Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial.Free Radic Biol Med. 2012. doi: 10.1016/j.freeradbiomed.2012.02.008
77. Zaccardi F, Pitocco D, Martini F, Caputo S, Miele L, Grieco A, Ghirlanda G. A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance. Acta Diabetol. 2012 Mar 3. doi: 10.1007/s00592-012-0382-5. PMID: 22389003
78. Gramenzi A, Conti F, Cammà C, Grieco A, Picciotto A, Furlan C, Romagno D, Costa P, Rendina M, Ancarani F, Chiaramonte M, Verucchi G, Craxì A, Bernardi M, Andreone P; for the AISF HepaElder Study Group.Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver. Dig Liver Dis. 2012 Aug;44(8):674-680.PMID: 22538206
79. Fracanzani L, Valenti L, Russello M, Miele L, Bertelli C, Bellia A, Masetti C, Grieco A, Marchesini G, Fargion S.Gallstone disease is associated with more severe liver damage in patients with Non-Alcoholic Fatty Liver Disease.PLoS One. 2012;7(7):e41183. Epub 2012 Jul 25.
80. Miele L, Cammarota C, Vero V, Racco S, Cefalo C, Pompili M, Rapaccini GL, Bianco A, Landolfi R, Gasbarrini A, Grieco A. Subjects with non-alcoholic fatty liver disease (NAFLD) have high prevalence of gastroesophageal reflux symptoms. Dig Liver Dis. 2012 Sep 7.PMID: 22963909
81. Gatto A, De Gaetano AM, Giuga M, Siciliani L, Miele L, Riccardi L, Pizzolante F, Rapaccini GL, Gasbarrini A, Giuliante F, Vecchio FM, Pompili M, Bonomo L. Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging. Abdom Imaging. 2013 Aug;38(4):736-44. doi: 10.1007/s00261-012-9950-y.
82. Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P. A 360-Degree Overview Of Paediatric Nafld: Recent Insights. J Hepatol. 2012 Dec 10. doi:pii: S0168-8278(12)00922-1. 10.1016/j.jhep.2012.12.003.PMID: 23238106
83. Barone C, Basso M, Biolato M, Pompili M, Rufini V, Miele L, Basso M, De Gaetano AM, Castaldi P, Iaculli A, Leccisotti L, Riccardi L, Grieco A.A phase II study of sunitinib in advanced hepatocellular carcinoma. Dig Liver Dis. 2013 Feb 11. doi:pii: S1590-8658(13)00003-0. 10.1016/j.dld.2013.01.002.PMID: 23410734
84. Miele L, Marrone G, Lauritano C, Gasbarrini A, Day CP, Grieco A. Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. Current Pharmaceutical Design. Curr Pharm Des. 2013;19(29):5314-24.
85. Biolato M, Miele L, Di Stasi C, Grieco A. A giant calcified hepatic mass. Ann Hepatol. 2013 Sep-Oct;12(5):822-3.
86. Addolorato G, Mirijello A, Leggio L, Ferrulli A, D'Angelo C, Vassallo G, Cossari A, Gasbarrini G, Landolfi R, Agnes S, Gasbarrini A, Gemelli OLT Group. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcoholism Clinical and Experimental Research. Alcohol Clin Exp Res. 2013 Sep;37(9):1601-8. doi: 10.1111/acer.12117. Epub 2013 Apr
87. Miele L, Marrone G, Cefalo C, D'Achille S, Rapaccini GL, Gasbarrini A, Grieco A. Potential use of liver function breath tests in the clinical practice.Eur Rev Med Pharmacol Sci. 2013 Dec;17 Suppl 2:82-9.
88. Pompili M, Biolato M, Miele L, Grieco A. Tumor necrosisfactor-α inhibitors and chronic hepatitis C: A comprehensive literaturereview. World J Gastroenterol 2013; 19(44): 7867-7873
89. Miele L, Dall’ArmiV, Cefaloa C, Nedovic B, Arzani D, Amore R, Rapaccini G,Gasbarrini A, Ricciardi W, Grieco A, Boccia S.A Case-Control Study on the effect of metabolic gene polymorphism, nutrition, and their interaction on the risk Non-Alcoholic Fatty Liver Disease. Genes Nutr. 2014 Mar; 9(2):383. doi: 10.1007/s12263-013-0383-1. Epub 2014 Jan 9.
90. Petta S, Miele L, Bugianesi E, Cammà C, Rosso C, Boccia S, Cabibi D, Di Marco V, Grimaudo S, Grieco A, Pipitone RM, Marchesini G, Craxì A.Glucokinase regulatory protein Gene Polymorphism Affects Liver Fibrosis in Non-alcoholic Fatty Liver Disease. PLoS One. 2014 Feb 3;9(2):e87523. doi: 10.1371/journal.pone.0087523. eCollection 2014.
91. Giorgio V, Miele L, Principessa L, Ferretti F, Villa MP, Negro V, Grieco A, Alisi A, Nobili V. Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity. Dig Liver Dis. 2014 Mar 12. pii: S1590-8658(14)00242-4. doi: 10.1016/j.dld.2014.02.010.
92. Balmer ML, Slack E, de Gottardi A, Lawson M, Hapfelmeier S, Miele L, Grieco A, Van Vlierberghe H, Fahrner R, Patuto N, Bernsmeier C, Ronchi F, Wyss M, Stroka D, Dickgreber N, Heim M, McCoy KD, Macpherson AJ. The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota. Sci Transl Med. 2014 May 21;6(237):237ra66. doi: 10.1126/scitranslmed.3008618.
93. Biolato M, Miele L, Vero V, Racco S, Di Stasi C, Iezzi R, Zanché A, Pompili M, Rapaccini GL, La Torre G, Gasbarrini A, Grieco A. Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival. World J Gastroenterol. 2014 Jul 7;20(25):8158-65. doi: 10.3748/wjg.v20.i25.8158.
94. Inchingolo R, De Gaetano AM, Curione D, Ciresa M, Miele L, Pompili M, Vecchio FM, Giuliante F, Bonomo L. Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver. Eur Radiol. 2014 Nov 28.